Piers Mook

1.6k total citations
34 papers, 778 citations indexed

About

Piers Mook is a scholar working on Food Science, Epidemiology and Infectious Diseases. According to data from OpenAlex, Piers Mook has authored 34 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Food Science, 11 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Piers Mook's work include Salmonella and Campylobacter epidemiology (14 papers), Food Safety and Hygiene (9 papers) and Listeria monocytogenes in Food Safety (8 papers). Piers Mook is often cited by papers focused on Salmonella and Campylobacter epidemiology (14 papers), Food Safety and Hygiene (9 papers) and Listeria monocytogenes in Food Safety (8 papers). Piers Mook collaborates with scholars based in United Kingdom, Sweden and Denmark. Piers Mook's co-authors include Iain Gillespie, S. O’Brien, C.L. Little, Kathie Grant, Paul Crook, Timothy J. Dallman, Claire Jenkins, Jim McLauchlin, Richard Pebody and Goutam K. Adak and has published in prestigious journals such as American Journal of Epidemiology, Journal of Clinical Microbiology and Annals of Oncology.

In The Last Decade

Piers Mook

32 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piers Mook United Kingdom 16 301 270 242 188 152 34 778
Juno Thomas South Africa 16 239 0.8× 485 1.8× 192 0.8× 425 2.3× 111 0.7× 50 1.1k
William N. Hall United States 15 289 1.0× 301 1.1× 235 1.0× 238 1.3× 168 1.1× 27 872
Shama D. Ahuja United States 16 573 1.9× 855 3.2× 171 0.7× 430 2.3× 139 0.9× 54 1.2k
Adam J. Langer United States 14 190 0.6× 540 2.0× 103 0.4× 312 1.7× 141 0.9× 32 850
Alberto Fíca Chile 13 164 0.5× 197 0.7× 48 0.2× 187 1.0× 124 0.8× 82 591
Johannes Dreesman Germany 12 189 0.6× 133 0.5× 100 0.4× 181 1.0× 111 0.7× 62 589
Lorenzo Pezzoli Switzerland 18 120 0.4× 170 0.6× 84 0.3× 215 1.1× 292 1.9× 47 809
Thomas Inns United Kingdom 14 295 1.0× 502 1.9× 95 0.4× 520 2.8× 169 1.1× 33 1.1k
Megge Miller Australia 15 206 0.7× 279 1.0× 88 0.4× 299 1.6× 131 0.9× 23 734
Paula Clogher United States 11 313 1.0× 543 2.0× 86 0.4× 174 0.9× 348 2.3× 19 840

Countries citing papers authored by Piers Mook

Since Specialization
Citations

This map shows the geographic impact of Piers Mook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piers Mook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piers Mook more than expected).

Fields of papers citing papers by Piers Mook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piers Mook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piers Mook. The network helps show where Piers Mook may publish in the future.

Co-authorship network of co-authors of Piers Mook

This figure shows the co-authorship network connecting the top 25 collaborators of Piers Mook. A scholar is included among the top collaborators of Piers Mook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piers Mook. Piers Mook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Jeremy, Piers Mook, Amy Gimma, et al.. (2025). Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe. Epidemiology and Infection. 153. e16–e16. 1 indexed citations
2.
Sinnathamby, Mary, et al.. (2024). Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe. Influenza and Other Respiratory Viruses. 18(5).
3.
Reynolds, Rosy, Helen Lambert, Matthew Hickman, et al.. (2023). Understanding adherence to self-isolation in the first phase of the COVID-19 pandemic in England: a cross-sectional mixed-methods study. BMC Public Health. 23(1). 2074–2074.
4.
Meslé, Margaux M. I., et al.. (2023). Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022. Influenza and Other Respiratory Viruses. 17(11). e13219–e13219. 21 indexed citations
5.
Kafatos, George, Piers Mook, André Charlett, et al.. (2020). Retrospective assessment of rapid outbreak investigation for gastrointestinal diseases using only cases and background exposure data. Epidemiology and Infection. 148. e60–e60. 1 indexed citations
6.
Mook, Piers, T J Meerhoff, Sonja J. Olsen, et al.. (2020). Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018. Influenza and Other Respiratory Viruses. 14(2). 150–161. 12 indexed citations
7.
Inns, Thomas, et al.. (2019). Are food exposures obtained through commercial market panels representative of the general population? Implications for outbreak investigations. Epidemiology and Infection. 147. e99–e99. 1 indexed citations
8.
9.
Mook, Piers, Sanch Kanagarajah, Marko Kerac, et al.. (2018). Use of gender distribution in routine surveillance data to detect potential transmission of gastrointestinal infections among men who have sex with men in England. Epidemiology and Infection. 146(11). 1468–1477. 21 indexed citations
10.
Mook, Piers, Jacquelyn McCormick, Sanch Kanagarajah, et al.. (2018). Online market research panel members as controls in case–control studies to investigate gastrointestinal disease outbreaks: early experiences and lessons learnt from the UK. Epidemiology and Infection. 146(4). 458–464. 8 indexed citations
11.
Mook, Piers, Sanch Kanagarajah, Helen Maguire, et al.. (2015). Selection of population controls for aSalmonellacase-control study in the UK using a market research panel and web-survey provides time and resource savings. Epidemiology and Infection. 144(6). 1220–1230. 14 indexed citations
12.
Amar, Corinne, C. C. Little, Iain Gillespie, Piers Mook, & Kathie Grant. (2014). Keeping it cool.. PubMed. 29–29. 1 indexed citations
13.
Amar, Corinne, Ruth Ruggles, Richard Elson, et al.. (2014). Pregnancy-associated listeriosis in England and Wales. Epidemiology and Infection. 143(2). 249–256. 45 indexed citations
14.
Mook, Piers, et al.. (2012). Existing medications among non-pregnancy-related listeriosis patients in England, 2007–2009. Epidemiology and Infection. 141(1). 36–44. 8 indexed citations
15.
Gillespie, Iain, Piers Mook, Goutam K. Adak, S. O’Brien, & Noel McCarthy. (2012). The “Case-Chaos Study” as an Adjunct or Alternative to Conventional Case-Control Study Methodology. American Journal of Epidemiology. 176(6). 497–505. 7 indexed citations
16.
Mook, Piers, Bijendra Patel, & Iain Gillespie. (2011). Risk factors for mortality in non-pregnancy-related listeriosis. Epidemiology and Infection. 140(4). 706–715. 20 indexed citations
17.
Gillespie, Iain, Piers Mook, C.L. Little, Kathie Grant, & Goutam K. Adak. (2010). Listeria monocytogenes Infection in the Over-60s in England Between 2005 and 2008: A Retrospective Case–Control Study Utilizing Market Research Panel Data. Foodborne Pathogens and Disease. 7(11). 1373–1379. 31 indexed citations
18.
Mook, Piers, S. O’Brien, & Iain Gillespie. (2010). Concurrent Conditions and Human Listeriosis, England, 1999–2009. Emerging infectious diseases. 17(1). 38–43. 78 indexed citations
19.
Mook, Piers, Kathie Grant, C.L. Little, George Kafatos, & Iain Gillespie. (2010). Emergence of pregnancy-related listeriosis amongst ethnic minorities in England and Wales. Eurosurveillance. 15(27). 17–23. 34 indexed citations
20.
Swart, Ann Marie, Sarah Burdett, Jonathan A. Ledermann, Piers Mook, & Mahesh Parmar. (2007). Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review. Annals of Oncology. 19(4). 688–695. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juno Thomas Breakdown of academic impact, for papers by William N. Hall Breakdown of academic impact, for papers by Shama D. Ahuja Breakdown of academic impact, for papers by Adam J. Langer Breakdown of academic impact, for papers by Alberto Fíca Breakdown of academic impact, for papers by Johannes Dreesman Breakdown of academic impact, for papers by Lorenzo Pezzoli Breakdown of academic impact, for papers by Thomas Inns Breakdown of academic impact, for papers by Megge Miller Breakdown of academic impact, for papers by Paula Clogher
Rankless by CCL
2026